Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage

Study:

The Evaluation of Patients With Acute Hypertension and Intracerebral Hemorrhage With Intravenous Clevidipine Treatment

Rationale:

n/a

Purpose:

The purpose of this study is to determine the efficacy and safety of clevidipine for treating acute hypertension (high blood pressure, defined as systolic blood pressure >160 mmHg) in patients with intracerebral hemorrhage (i.e., bleeding in the brain; stroke).

Study Status: Completed

Recruiting:
n/a

Condition Intervention Phase
Hypertension
Hemorrhage
Drug: clevidipine Phase 3

Verified by The Medicines Company February, 2013

Sponsored by: The Medicines Company
Information provided by: The Medicines Company
ClinicalTrials.gov identifier: NCT00666328

Study Type: Interventional

Study Design: Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Cleveland Clinic Hospitals
Cleveland, Ohio 44195
United States

Carmelo Graffagnino, MD., Principal Investigator

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.

Cleveland Clinic Mobile Site